Drug Utilization Study of eliglustat in the US population using MarketScan® Database (ELIGLC06912)

First published 21/09/2017

Last updated 25/06/2024

EU PAS number:

EUPAS21025

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

CLB-DOC-72938 on 01Aug2018

English (554.75 KB - PDF)View document

Study results

Study results

study-report-eligl06912

English (911.36 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents